gmp-orphan

Providing access to innovative treatments for patients with rare diseases

Welcome to gmp-orphan

Identifying, developing and providing access to innovative treatments to patients with rare diseases.

At gmp-orphan (GMPO), it is our mission to identify, develop and provide access to innovative treatments to patients with rare diseases. Our experienced pharmaceutical development and commercial team in the field of rare diseases is critical in advancing this mission.

gmp-orphan (GMPO) was founded in 2011 and the company’s most advanced product candidate is Cuprior for the treatment of Wilson Disease.

Find out more

About Us
For Patients
Patient Support

Latest news

Vivamus magna justo, lacinia eget conse ctetur sed convallis tellus curabitur aliquet quam id dui posuere blandit cras ultricies ligula sed magna dictum porta.

Find out more about what we do and our innovative research into Wilson Disease

Get In Touch

Find out more about GMPO, who we are and what we do by emailing us click on the button below:

Start typing and press Enter to search